Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00034925.xml
Download PDF
Hamostaseologie 1981; 01(03): 87-90
DOI: 10.1055/s-0038-1656595
DOI: 10.1055/s-0038-1656595
Originalarbeiten
Die Rolle der Aggregationshemmer in der Therapie und Prophylaxe des Herzinfarktes
Further Information
Publication History
Publication Date:
21 June 2018 (online)
-
LITERATUR
- 1 Acheson J, Danta G, Hutchinson E. C. Controlled trial of dipyridamole in cerebral vascular disease. Brit. med. J 1969; 1: 614-615.
- 2 The Canadian Cooperative Study Group A randomized trial of aspirin and sulfinpyrazone in threatened stroke. New Engl. J. Med 1978; 299: 53-59.
- 3 Robertson J. T. Memphis-Studie. In: Price T. R, Nelson E. Cerebrovascular Diseases Raven Press; New York: 1979
- 4 Fields W. S, Lemak N. A, Franko wski R. R, Hardy R. J. Controlled trial of aspirin in cerebral ischemia. Stroke 1977; 8: 301-316.
- 5 Fields W. S, Lemak N. A, Frankows-ki R. F, Hardy R. J. Controlled trial of aspirin in cerebral ischemia. Part II: Surgical group. Stroke 1978; 9: 309-319.
- 6 Reuther R, Dorndorf W. Aspirin in patients with cerebral ischemia and normal angiograms or non-surgical lesions. In: Breddin K, Dorndorf W, Loew D, Marx R. (Hrsg.): Acetylsalicylic acid in cerebral ischemia and coronary heart disease Schattauer; Stuttgart: 1977
- 7 Worthington J. W, O’Fallon W, Fu-ster W, Whisnant J. P, Kurland L. T. Effect of Aspirin in prevention of coronary and cerebrovascular disease in patients with rheumatoid arthritis. Mayo Clin. Proc 1978; 53: 581-586.
- 8 Olsson J-E, Brechter C, Bäcklund H, Krook H, Müller R, Nitelius E, Olsson O, Tornberg A. Antikoagulant vs Anti-Platelet therapy as prophylactic against cerebral infarction in transient ischemic attacks. Stroke 1980; 11: 4-9.
- 9 The Persantine-Aspirin Reinfarction Study Research Group Persantine and aspirin in coronary heart disease. Circulation 1980; 62: 449-461.
- 10 Aspirin Myocardial Infarction Study Research Group A randomized, controlled trial of aspirin in persons recovered from myocardial infarction. JAMA 1980; 243: 661-669.
- 11 Barnett H. J. M. Aspirin zur Verhütung des Schlaganfalls. In: Breddin K, Loew D, Überla K, Dorndorf W, Marx R. (Hrsg.): Prophylaxe venöser, peripherer, kardialer und zerebraler Gefäßkrankheiten mit Azetylsalizylsäure Schattauer; Stuttgart: 1981
- 12 Kurtzke J. F. Critique of the Canadian »TIA« Study. In: Price T. R, Nelson E. Cerebrovascular Diseases Raven Press; New York: 1979
- 13 Dyken M. D. Antiplatelet aggregating agents in transient ischemic attacks and the relationship of risk factors. In: Breddin K, Loew D, Überla K, Domdorf W, Marx R. (Hrsg.): Prophylaxe venöser, peripherer, kardialer und zerebraler Gefäßkrankheiten mit Azetylsalizylsäure Schattauer; Stuttgart: 1981
- 14 Fields W. S. Persönl. Mitteilung 1980
- 15 Sandok B. A, Furlan A. J, Whisnant J. P, Sundt T. M. Guidelines for the manage ment of transient ischemic attacks. Mayo Clin. Proc 1978; 53: 665-674.